Junhui Yu
Impact in
- Nephrology top 5%
- Gout, Hyperuricemia, Uric Acid
-
- Inflammasome and immune disorders
- Heme Oxygenase-1 and Carbon Monoxide
- RNA modifications and cancer
Papers in
-
- Inflammasome and immune disorders 5
- Ubiquitin and proteasome pathways 2
- Wnt/β-catenin signaling in development and cancer 2
-
- Cancer-related molecular mechanisms research 3
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Xuejun Sun (13 shared papers)Zilu Chen (8 shared papers)Jianbao Zheng (10 shared papers)Jing Guo (5 shared papers)Jie Qi (4 shared papers)Yunhua Wu (2 shared papers)Kai Wang (2 shared papers)Shan Li (1 shared paper)
- Journals
- iScience (2 papers)Cell Cycle (2 papers)International Journal of Oncology (2 papers)Optics & Laser Technology (2 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaSouth Korea
In The Last Decade
Junhui Yu
24 papers receiving 722 citations
Junhui Yu's Hit Papers
Peers
Comparison fields: 5 of 77
- Nephrology 96
- Molecular Biology 521
- Cancer Research 105
- Immunology 148
- Molecular Medicine 29
Countries citing papers authored by Junhui Yu
This map shows the geographic impact of Junhui Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhui Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhui Yu more than expected).
Fields of papers citing papers by Junhui Yu
This network shows the impact of papers produced by Junhui Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhui Yu. The network helps show where Junhui Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junhui Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells Hit paper breakdown → | 2019 | 401 |
| 2 | 2021 | 56 | |
| 3 | 2022 | 29 | |
| 4 | 2023 | 28 | |
| 5 | 2018 | 28 | |
| 6 | 2018 | 26 | |
| 7 | 2022 | 23 | |
| 8 | 2017 | 22 | |
| 9 | 2023 | 17 | |
| 10 | 2021 | 17 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 11 | |
| 13 | 2021 | 10 | |
| 14 | 2018 | 10 | |
| 15 | 2024 | 9 | |
| 16 | 2015 | 7 | |
| 17 | 2024 | 6 | |
| 18 | 2025 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2025 | 1 |
About Junhui Yu
Junhui Yu is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Atomic and Molecular Physics, and Optics, having authored 26 papers that have together received 724 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (5 papers), Laser-Matter Interactions and Applications (3 papers), Cancer-related molecular mechanisms research (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Ubiquitin and proteasome pathways (2 papers), Orbital Angular Momentum in Optics (2 papers), Cancer Cells and Metastasis (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Nephrology (96 citations), Molecular Biology (521 citations), Cancer Research (105 citations), Immunology (148 citations) and Molecular Medicine (29 citations). Junhui Yu has collaborated with scholars based in China and South Korea. Frequent co-authors include Xuejun Sun, Zilu Chen, Jianbao Zheng, Jing Guo, Jie Qi, Yunhua Wu, Kai Wang, Shan Li, Zhengshui Xu and Qi Gao. Their work appears in journals such as iScience, Cell Cycle, International Journal of Oncology, Optics & Laser Technology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.